Cargando…

Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects

Patients with hematological disorders and severe thrombocytopenia require extensive and iterative platelet transfusion support. In these patients, platelet transfusion refractoriness represents a serious adverse transfusion event with major outcomes for patient care. Recipient alloantibodies against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Couvidou, Adèle, Rojas-Jiménez, Gabriel, Dupuis, Arnaud, Maître, Blandine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947338/ https://www.ncbi.nlm.nih.gov/pubmed/36845153 http://dx.doi.org/10.3389/fimmu.2023.1125367

Ejemplares similares

Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice
por: Couvidou, Adèle, et al.
Publicado: (2022)

Discriminating young platelets on human leukocyte antigen-I expression highlights their extremely high reactivity potential
por: Angénieux, Catherine, et al.
Publicado: (2023)

Altered Fc glycosylation of anti‐HLA alloantibodies in hemato‐oncological patients receiving platelet transfusions
por: van Osch, Thijs L. J., et al.
Publicado: (2022)

Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion
por: Patel, Seema R., et al.
Publicado: (2018)

Depletion of donor-specific anti-HLA A2 alloantibodies in a hematopoietic cell transplant recipient using directed mismatched platelet transfusions
por: Spriewald, Bernd M., et al.
Publicado: (2018)

HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined
por: El-Awar, Nadim, et al.
Publicado: (2017)

Divergent CD4(+) T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients
por: Khelfa, Mehdi, et al.
Publicado: (2023)

Autoantibodies mimicking alloantibodies: A case series unveiling the dilemmas of transfusion
por: Agrawal, Soma, et al.
Publicado: (2023)

Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen
por: Hickey, Michelle J., et al.
Publicado: (2016)

Germinal Center Alloantibody Responses Mediate Progression of Chronic Allograft Injury
por: Chhabra, Manu, et al.
Publicado: (2019)

Characterization of post-transfusion anti-FEA 1 alloantibodies in transfusion-naive FEA 1-negative cats
por: Cannavino, Alyssa, et al.
Publicado: (2022)

Post-transfusion purpura in an African-American man due to human platelet antigen-5b alloantibody: a case report
por: Lynce, Filipa, et al.
Publicado: (2012)

Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum
por: Won, Dong Il, et al.
Publicado: (2020)

Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients
por: Zhang, Jing-Cheng, et al.
Publicado: (2023)

Evaluation and management of platelet transfusion refractoriness
por: Youk, Hee-Jeong, et al.
Publicado: (2022)

Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in Yazd
por: Vaziri, M, et al.
Publicado: (2015)

Platelet Transfusion – The New Immunology of an Old Therapy
por: Stolla, Moritz, et al.
Publicado: (2015)

Bovine Neonatal Pancytopenia-Associated Alloantibodies Recognize Individual Bovine Leukocyte Antigen 1 Alleles
por: Kasonta, Rahel, et al.
Publicado: (2018)

Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies.
por: Lee, M., et al.
Publicado: (1988)

Regulation of Alloantibody Responses
por: Chong, Anita S., et al.
Publicado: (2021)

Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusions
por: Agarwal, Nitin, et al.
Publicado: (2014)

Single blood transfusion induces the production of donor-specific alloantibodies and regulatory T cells mainly in the spleen
por: Ueta, Hisashi, et al.
Publicado: (2018)

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates
por: Daligault, Mélanie, et al.
Publicado: (2021)

Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering
por: Figueiredo, Constanca, et al.
Publicado: (2021)

Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
por: van Osch, Thijs L.J., et al.
Publicado: (2022)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion
por: Saris, Anno, et al.
Publicado: (2018)

HLA Class II Genes HLA-DRB1, HLA-DPB1, and HLA-DQB1 Are Associated With the Antibody Response to Inactivated Japanese Encephalitis Vaccine
por: Yao, Yufeng, et al.
Publicado: (2019)

HLA Class I or Class II and Disease Association: Catch the Difference If You Can
por: Fiorillo, Maria Teresa, et al.
Publicado: (2017)

Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate
por: Pessoni, Lívia Lara, et al.
Publicado: (2018)

Alloantibody among Thalassemia patients receiving multiple blood transfusions at a tertiary care hospital in India
por: Thakur, Sanjay Kumar, et al.
Publicado: (2023)

Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion
por: Belizaire, Roger, et al.
Publicado: (2020)

HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia
por: Djurisic, Snezana, et al.
Publicado: (2014)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
Publicado: (2023)

Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction
por: Wendorff, Mareike, et al.
Publicado: (2020)

Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance
por: Denzin, Lisa K.
Publicado: (2013)

Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model
por: Manook, Miriam, et al.
Publicado: (2021)

Simultaneous genotyping for human platelet antigen systems and HLA-A and HLA-B loci by targeted next-generation sequencing
por: Wang, Jielin, et al.
Publicado: (2022)

Acute hemolytic transfusion reactions due to multiple alloantibodies including anti-E, anti-c and anti-Jkb.
por: Park, Tae Sung, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_2a1pgl8j6o1ubibtm5co4b94o9